# Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts

> **NCT00283413** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 514 (actual)

## Conditions studied

- Symptomatic Ischemic Saphenous Vein Graft Disease

## Interventions

- **DEVICE:** Covered Stent System
- **DEVICE:** Bare metal stent

## Key facts

- **NCT ID:** NCT00283413
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2004-05
- **Final completion:** 2009-03
- **Target enrollment:** 514 (ACTUAL)
- **Last updated:** 2009-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00283413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00283413, "Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00283413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*